Skip to content
Clinical Trials – home
PolandBack to Poland

Clinical trials in Opole – page 9

142 clinical trials in Opole, Poland across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

PolandOur site in PolandBadaniaKliniczne.pl(opens in a new tab)
Opole at a glance
142
clinical trials
  • Research sites2
Type of trial
Recruitment status
Quick filters

142 trials in Opole

Open in trial search

Embolism venous

Not recruiting
Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Enoxaparin Sodium
  • Sponsor:Sirius Therapeutics Inc.
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Risankizumab
  • Sponsor:AbbVie Deutschland GmbH & Co. KG
Countries:PolandPoland
  • Participants:18–64 years
  • Substances:Capecitabine
  • Sponsor:AstraZeneca AB
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Abiraterone
  • Sponsor:Celgene Corp.

Stress cardiomyopathy

Not recruiting
Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Glucose Monohydrate
  • Sponsor:Medical University Of Gdansk
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Enalapril Maleate
  • Sponsor:Agencja Badań Medycznych

Cardiac failure acute

Not recruiting
Registered drug
Countries:PolandPoland
  • Participants:18–64 years
  • Substances:Dapagliflozin
  • Sponsor:Medical University Of Warsaw
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:1-4-{[6-Amino-5-(4-Phenoxy-Phenyl)-Pyrimidin-4-Ylamino]-Methyl}-4-Fluoro-Piperidin-1-Yl)-Propenone
  • Sponsor:Telios Pharma Inc.
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Dexamethasone
  • Sponsor:Pfizer Inc.

Cardiogenic shock

Not recruiting
Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Istaroxime
  • Sponsor:Windtree Therapeutics Inc.
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Palbociclib
  • Sponsor:ABCSG GmbH
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:Exelixis Inc.

Other cities in Poland

The busiest research cities in the country

All 238 cities in Poland

Clinical research in Opole

What the registry says about research in the country

01 Cardiovascular Research

Innovative studies focusing on heart failure treatments, including investigations of medications like sacubitril/valsartan for various cardiac conditions. Research encompasses both acute and chronic heart conditions.

  • Heart Failure Management
  • Cardiogenic Shock Treatment
  • Post-Infarction Care

Multiple trials exploring treatments for patients with reduced ejection fraction and acute cardiac conditions.

02 Oncology Studies

Comprehensive research into various cancer types, with particular focus on breast cancer and prostate cancer treatments. Studies evaluate novel therapeutic approaches and drug combinations.

  • Metastatic Cancer Treatments
  • Targeted Therapies
  • Colorectal Cancer Research

Investigations include both early-stage and advanced cancer treatments using innovative therapeutic agents.

03 Immunology and Inflammation

Studies examining treatments for autoimmune conditions and inflammatory disorders, including research on novel therapies for psoriatic arthritis and urticaria.

  • Arthritis Management
  • Inflammatory Bowel Disease
  • Immune System Disorders

Clinical investigations focus on improving patient outcomes through targeted immunological interventions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.